Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Shoji T, Takatori E, Omi H, Kagabu M, et al. A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study). Cancer Chemother Pharmacol 2017 Jun 27. doi: 10.1007/s00280-017-3363.
PMID: 28656383


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016